Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A conceptualized model linking matrix metalloproteinase-9 to schizophrenia pathogenesis.

Bitanihirwe BKY, Woo TW.

Schizophr Res. 2020 Jan 27. pii: S0920-9964(19)30585-7. doi: 10.1016/j.schres.2019.12.015. [Epub ahead of print]

PMID:
32001079
2.

A comparison of neurocognition and functioning in first episode psychosis populations: do research samples reflect the real world?

Kline E, Hendel V, Friedman-Yakoobian M, Mesholam-Gately RI, Findeisen A, Zimmet S, Wojcik JD, Petryshen TL, Woo TW, Goldstein JM, Shenton ME, Keshavan MS, McCarley RW, Seidman LJ.

Soc Psychiatry Psychiatr Epidemiol. 2019 Mar;54(3):291-301. doi: 10.1007/s00127-018-1631-x. Epub 2018 Nov 28.

PMID:
30488086
3.

Gene expression profile associated with postnatal development of pyramidal neurons in the human prefrontal cortex implicates ubiquitin ligase E3 in the pathophysiology of schizophrenia onset.

Kohlbrenner EA, Shaskan N, Pietersen CY, Sonntag KC, Woo TW.

J Psychiatr Res. 2018 Jul;102:110-117. doi: 10.1016/j.jpsychires.2018.03.013. Epub 2018 Apr 3.

4.

Laser microdissection and gene expression profiling in the human postmortem brain.

Sonntag KC, Woo TW.

Handb Clin Neurol. 2018;150:263-272. doi: 10.1016/B978-0-444-63639-3.00018-9.

PMID:
29496145
5.

What can we learn about brain donors? Use of clinical information in human postmortem brain research.

Sullivan K, Pantazopoulos H, Liebson E, Woo TW, Baldessarini RJ, Hedreen J, Berretta S.

Handb Clin Neurol. 2018;150:181-196. doi: 10.1016/B978-0-444-63639-3.00014-1. Review.

PMID:
29496141
6.

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.

Conus P, Seidman LJ, Fournier M, Xin L, Cleusix M, Baumann PS, Ferrari C, Cousins A, Alameda L, Gholam-Rezaee M, Golay P, Jenni R, Woo TW, Keshavan MS, Eap CB, Wojcik J, Cuenod M, Buclin T, Gruetter R, Do KQ.

Schizophr Bull. 2018 Feb 15;44(2):317-327. doi: 10.1093/schbul/sbx093.

7.

Cell Type-Specific Laser Capture Microdissection for Gene Expression Profiling in the Human Brain.

Mauney SA, Woo TW, Sonntag KC.

Methods Mol Biol. 2018;1723:203-221. doi: 10.1007/978-1-4939-7558-7_11.

PMID:
29344862
8.

Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia.

Mauney SA, Pietersen CY, Sonntag KC, Woo TW.

Schizophr Res. 2015 Dec;169(1-3):374-380. doi: 10.1016/j.schres.2015.10.042. Epub 2015 Nov 14.

9.

Increased extracellular clusterin in the prefrontal cortex in schizophrenia.

Athanas KM, Mauney SL, Woo TW.

Schizophr Res. 2015 Dec;169(1-3):381-385. doi: 10.1016/j.schres.2015.10.002. Epub 2015 Oct 21.

10.
11.

General pharmacological properties of YJA20379-2, a new antiulcer agent.

Lee EB, Cho SI, Cheon SA, Chang MS, Kim KB, Woo TW, Chung YK.

Arch Pharm Res. 2000 Feb;23(1):72-8.

PMID:
10728661
12.
13.
14.

The biochemical and pharmacological properties of a newly synthesized H+-K+ ATPase inhibitor, 2-dimethylamino-4,5-dihydrothiazolo[4,5:3,4]pyridol-[1,2-a]benzimidazol e.

Chung YK, Chang MS, Kim KB, Sohn SK, Woo TW, Lee SB, Choi WS.

Can J Physiol Pharmacol. 1998 Sep;76(9):921-9.

PMID:
10066143
15.

Inhibitory action of YJA20379, a new proton pump inhibitor on Helicobacter pylori growth and urease.

Woo TW, Chang MS, Chung YK, Kim KB, Sohn SK, Kim SG, Choi WS.

Arch Pharm Res. 1998 Feb;21(1):6-11.

PMID:
9875507
16.

Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats.

Woo TW, Chang MS, Chung YK, Kim KB, Sohn SK, Kim SG, Choi WS.

Biol Pharm Bull. 1998 May;21(5):449-55.

PMID:
9635498

Supplemental Content

Support Center